Vivos Therapeutics (VVOS) Intangibles (2019 - 2026)

Vivos Therapeutics (VVOS) reported Intangibles of $3.8 million for Q1 2026, up 972.35% year-over-year from $358000.0 in Q1 2025, and down 5.09% quarter-over-quarter from $4.0 million in Q4 2025.

Vivos Therapeutics (VVOS) Intangibles (2019 - 2026) Analysis & Trends

Vivos Therapeutics (VVOS) has 8 years of Intangibles data on file, last reported at $3.8 million in Q1 2026.

  • Intangibles for Q1 2026 came in at $3.8 million, up 972.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (up 972.35% YoY), and the FY2025 annual result was $4.0 million, up 889.0% from the prior year.
  • Intangibles declined to $3.8 million in Q1 2026 per VVOS's latest filing, from $4.0 million in the prior quarter.
  • Over five years, Intangibles peaked at $4.0 million in Q4 2025 and troughed at $302000.0 in Q4 2022.
  • A 5-year average of $1.0 million and a median of $409000.0 in 2024 frame the typical range for Intangibles.
  • The sharpest annual moves came in 2022 and 2026: Intangibles declined 21.94% in 2022, then surged 972.35% in 2026.
  • A 5-year view of Intangibles shows it stood at $302000.0 in 2022, then soared by 39.07% to $420000.0 in 2023, then dropped by 2.62% to $409000.0 in 2024, then soared by 889.0% to $4.0 million in 2025, then slipped by 5.09% to $3.8 million in 2026.
  • Business Quant data shows VVOS's Intangibles at $3.8 million in Q1 2026, $4.0 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.88 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 5.52 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 10.34 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 7.06 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 1.23 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.14 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 62.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 1.91 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.62 Bn
10 Vivos Therapeutics 7.39 Mn 5.16 Mn 3.06 Mn 3.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.84 Mn
Dec 31, 2025 4.05 Mn
Sep 30, 2025 2.17 Mn
Jun 30, 2025 2.23 Mn
Mar 31, 2025 358,000.00
Dec 31, 2024 409,000.00
Sep 30, 2024 383,000.00
Jun 30, 2024 395,000.00
Mar 31, 2024 408,000.00
Dec 31, 2023 420,000.00
Sep 30, 2023 433,000.00
Jun 30, 2023 445,000.00
Mar 31, 2023 458,000.00
Dec 31, 2022 302,000.00
Sep 30, 2022 312,000.00
Jun 30, 2022 322,000.00
Mar 31, 2022 331,000.00
Dec 31, 2021 341,000.00
Sep 30, 2021 350,585.00
Jun 30, 2021 412,513.00